REMED CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,580 KRW | +0.99% |
|
+2.29% | +9.98% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 76,863 | 1,99,108 | 1,62,688 | 75,676 | 99,727 |
| Enterprise Value (EV) 1 | 68,390 | 1,77,070 | 1,45,901 | 64,605 | 1,11,784 |
| P/E ratio | 15.9 x | -107 x | 216 x | 42 x | 125 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 4.14 x | 12 x | 8.06 x | 3.54 x | 5.38 x |
| EV / Revenue | 3.69 x | 10.6 x | 7.22 x | 3.02 x | 6.03 x |
| EV / EBITDA | 14.6 x | 85.2 x | 86.6 x | 26.7 x | -58.7 x |
| EV / FCF | - | 26,32,55,156 x | -1,52,42,113 x | 29,60,964 x | -43,14,395 x |
| FCF Yield | - | 0% | -0% | 0% | -0% |
| Price to Book | 3.12 x | 8.03 x | 6.23 x | 2.53 x | 3.24 x |
| Nbr of stocks (in thousands) | 29,115 | 30,445 | 30,638 | 30,638 | 30,638 |
| Reference price 2 | 2,640 | 6,540 | 5,310 | 2,470 | 3,255 |
| Announcement Date | 22/03/21 | 22/03/21 | 18/03/22 | 17/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 18,550 | 16,633 | 20,195 | 21,363 | 18,536 |
| EBITDA 1 | 4,675 | 2,079 | 1,684 | 2,417 | -1,905 |
| EBIT 1 | 4,288 | 1,684 | 1,123 | 1,661 | -2,860 |
| Operating Margin | 23.11% | 10.12% | 5.56% | 7.78% | -15.43% |
| Earnings before Tax (EBT) 1 | 4,589 | -2,279 | 883.1 | 4,560 | 979.7 |
| Net income 1 | 4,363 | -1,834 | 752.3 | 4,000 | 797.2 |
| Net margin | 23.52% | -11.02% | 3.73% | 18.72% | 4.3% |
| EPS 2 | 166.4 | -61.20 | 24.60 | 58.82 | 26.00 |
| Free Cash Flow | - | 672.6 | -9,572 | 21,819 | -25,910 |
| FCF margin | - | 4.04% | -47.4% | 102.13% | -139.78% |
| FCF Conversion (EBITDA) | - | 32.35% | - | 902.85% | - |
| FCF Conversion (Net income) | - | - | - | 545.45% | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 22/03/21 | 22/03/21 | 18/03/22 | 17/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q4 |
|---|---|---|---|
| Net sales 1 | 4.654 | 6.666 | 5.162 |
| EBITDA | - | - | - |
| EBIT 1 | 0.3958 | - | 0.3244 |
| Operating Margin | 8.5% | - | 6.28% |
| Earnings before Tax (EBT) | - | - | - |
| Net income | 0.6929 | - | - |
| Net margin | 14.89% | - | - |
| EPS | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 17/11/21 | 11/02/22 | 17/03/23 |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 12,057 |
| Net Cash position 1 | 8,473 | 22,038 | 16,787 | 11,071 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -6.328 x |
| Free Cash Flow | - | 673 | -9,572 | 21,819 | -25,910 |
| ROE (net income / shareholders' equity) | - | -7.42% | 2.96% | 14.1% | 1.05% |
| ROA (Net income/ Total Assets) | - | 1.94% | 0.93% | 1.34% | -2.68% |
| Assets 1 | - | -94,448 | 80,739 | 2,99,254 | -29,702 |
| Book Value Per Share 2 | 846.0 | 814.0 | 852.0 | 977.0 | 1,006 |
| Cash Flow per Share 2 | 523.0 | 344.0 | 339.0 | 171.0 | 155.0 |
| Capex 1 | 2,010 | 680 | 4,134 | 4,951 | 791 |
| Capex / Sales | 10.83% | 4.09% | 20.47% | 23.17% | 4.27% |
| Announcement Date | 22/03/21 | 22/03/21 | 18/03/22 | 17/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.98% | 79.85M | |
| +11.15% | 227B | |
| +15.34% | 198B | |
| +18.12% | 142B | |
| +31.34% | 111B | |
| +1.56% | 64.16B | |
| +18.15% | 54.1B | |
| +5.12% | 51.41B | |
| +10.70% | 45.32B | |
| +5.12% | 37.32B |
- Stock Market
- Equities
- A302550 Stock
- Financials Remed Co.,Ltd.
